| Followers | 200 |
| Posts | 25597 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Sunday, April 07, 2024 8:37:01 AM
Parliament did not push the COVID vaccine through over MHRA’s protests. Quit it with the nonsense. This is not the place for this anti-vax garbage.
For COVID-19 vaccines, regulatory processes were expedited to make vaccines available as quickly as possible to respond to the public health emergency. Since then, they have reformed and decided to broadly apply the new expedited regime. However, this expediting regime was never meant bypassing the MHRA or the CHM. In fact, amendments were made to the Human Medicines Regulations in 2012 to allow for temporary authorisation of an unlicensed product in response to a public health threat, but only if specific conditions of safety, quality, and efficacy set out by the MHRA were met. The MHRA, with advice from the CHM, was still responsible for reviewing and granting temporary authorisation for COVID-19 vaccines, ensuring that they met stringent standards through a comprehensive clinical trial program .
For COVID-19 vaccines, regulatory processes were expedited to make vaccines available as quickly as possible to respond to the public health emergency. Since then, they have reformed and decided to broadly apply the new expedited regime. However, this expediting regime was never meant bypassing the MHRA or the CHM. In fact, amendments were made to the Human Medicines Regulations in 2012 to allow for temporary authorisation of an unlicensed product in response to a public health threat, but only if specific conditions of safety, quality, and efficacy set out by the MHRA were met. The MHRA, with advice from the CHM, was still responsible for reviewing and granting temporary authorisation for COVID-19 vaccines, ensuring that they met stringent standards through a comprehensive clinical trial program .
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
